Claragen, Inc.
Records under this name other than patents Claragen, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 3 of 3 · Back to Claragen, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,599,031 | Optical/electrical interconnects and package for high speed signaling Formerly held Term ended Term ended Sep 12, 2021 · USPTO record | Term ended | Term ended Sep 12, 2021 | USPTO record |
| US 7,122,344 | Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions Formerly held Term ended Term ended Sep 22, 2017 · USPTO record | Term ended | Term ended Sep 22, 2017 | USPTO record |
| US 6,255,281 | Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions Formerly held Term ended Term ended May 28, 2017 · USPTO record | Term ended | Term ended May 28, 2017 | USPTO record |